Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.

ContextThe Women's Health Initiative Memory Study (WHIMS) previously reported that estrogen plus progestin therapy does not protect cognition among women aged 65 years or older. The effect of estrogen-alone therapy, also evaluated in WHIMS, on cognition has not been established for this population.ObjectivesTo determine whether conjugated equine estrogen (CEE) alters global cognitive function in older women and to compare its effect with CEE plus medroxyprogesterone acetate (CEE plus MPA).Design, Setting, and ParticipantsA randomized, double-blind, placebo-controlled ancillary study of the Women's Health Initiative (WHI), WHIMS evaluated the effect of CEE on incidence of probable dementia among community-dwelling women aged 65 to 79 years with prior hysterectomy from 39 US academic centers that started in June 1995. Of 3200 eligible women free of probable dementia enrolled in the WHI, 2947 (92.1%) were enrolled in WHIMS. Analyses were conducted on the 2808 women (95.3%) with a baseline and at least 1 follow-up measure of global cognitive function before the trial's termination on February 29, 2004.InterventionsParticipants received 1 daily tablet containing either 0.625 mg of CEE (n = 1387) or matching placebo (n = 1421).Main Outcome MeasureGlobal cognitive function measured annually with the Modified Mini-Mental State Examination (3MSE).ResultsDuring a mean follow-up of 5.4 years, mean (SE) 3MSE scores were 0.26 (0.13) units lower than among women assigned to CEE compared with placebo (P = .04). For pooled hormone therapy (CEE combined with CEE plus MPA), the mean (SE) decrease was 0.21 (0.08; P = .006). Removing women with dementia, mild cognitive impairment, or stroke from the analyses lessened these differences. The adverse effect of hormone therapy was more pronounced among women with lower cognitive function at baseline (all P<.01). For women assigned to CEE compared with placebo, the relative risk of having a 10-unit decrease in 3MSE scores (>2 SDs) was estimated to be 1.47 (95% confidence interval, 1.04-2.07).ConclusionFor women aged 65 years or older, hormone therapy had an adverse effect on cognition, which was greater among women with lower cognitive function at initiation of treatment.

[1]  R. Bland,et al.  Mild Dementia or Cognitive Impairment: The Modified Mini-Mental State Examination (3MS) as a Screen for Dementia , 2001, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[2]  F. Plum,et al.  Mental Status Testing in the Elderly Nursing Home Population , 1995, Journal of geriatric psychiatry and neurology.

[3]  G. Bravo,et al.  Reliability of the Modified Mini-Mental State Examination in the context of a two-phase community prevalence study. , 1997, Neuroepidemiology.

[4]  Janice E Graham,et al.  Prevalence and severity of cognitive impairment with and without dementia in an elderly population , 1997, The Lancet.

[5]  L. Thal,et al.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.

[6]  I McDowell,et al.  Community screening for dementia: the Mini Mental State Exam (MMSE) and Modified Mini-Mental State Exam (3MS) compared. , 1997, Journal of clinical epidemiology.

[7]  JoAnn E. Manson,et al.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. , 1998, Controlled clinical trials.

[8]  D. Wysowski,et al.  Use of Menopausal Estrogens and Medroxyprogesterone in the United States, 1982–1992 , 1995, Obstetrics and gynecology.

[9]  K. Yaffe,et al.  Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. , 1998, JAMA.

[10]  Susan R. Johnson,et al.  The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. , 2003, Annals of epidemiology.

[11]  J. Janowsky,et al.  Hormone replacement therapy and cognition: systematic review and meta-analysis. , 2001, JAMA.

[12]  C. Toran-Allerand.  Organotypic culture of the developing cerebral cortex and hypothalamus: Relevance to sexual differentiation , 1991, Psychoneuroendocrinology.

[13]  Brenda L Plassman,et al.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. , 2002, JAMA.

[14]  R. Gibbs.  Estrogen Replacement Enhances Acquisition of a Spatial Memory Task and Reduces Deficits Associated with Hippocampal Muscarinic Receptor Inhibition , 1999, Hormones and Behavior.

[15]  M A Espeland,et al.  The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. , 1998, Controlled clinical trials.

[16]  J. Zhang,et al.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. , 1998, JAMA.

[17]  H. Chui,et al.  The Modified Mini-Mental State (3MS) examination. , 1987, The Journal of clinical psychiatry.

[18]  Oscar L. Lopez,et al.  Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[19]  Estrogen Replacement Therapy and Cognitive Decline in Older Community Women , 1999, Journal of the American Geriatrics Society.

[20]  M. Mattson,et al.  Estrogens Attenuate and Corticosterone Exacerbates Excitotoxicity, Oxidative Injury, and Amyloid β‐Peptide Toxicity in Hippocampal Neurons , 1996, Journal of neurochemistry.

[21]  J. Zubieta,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Effects of Long-Term Hormone Therapy on Cholinergic Synaptic Concentrations in Healthy , 2022 .

[22]  Anita M. Hubley,et al.  Mini-Mental State Examination (MMSE) and the Modified MMSE (3MS): A psychometric comparison and normative data. , 1996 .

[23]  B. Klein,et al.  Postmenopausal hormone therapy and its association with cognitive impairment. , 2003, Archives of internal medicine.

[24]  John Robbins,et al.  National cross sectional survey to determine whether the decision to delivery interval is critical in emergency caesarean section , 2004, BMJ : British Medical Journal.

[25]  J. Manson,et al.  Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003, JAMA.

[26]  K. Matthews,et al.  Prior to use of estrogen replacement therapy, are users healthier than nonusers? , 1996, American journal of epidemiology.

[27]  J. Morrison,et al.  Cyclic Estrogen Replacement Improves Cognitive Function in Aged Ovariectomized Rhesus Monkeys , 2003, The Journal of Neuroscience.

[28]  Richard F. Thompson,et al.  Estrogen and Neural Plasticity , 2000 .

[29]  H. Semlitsch,et al.  Double-blind, Placebo-controlled Psychometric Studies on the Effects of a Combined Estrogen-progestin Regimen versus Estrogen Alone on Performance, Mood and Personality of Menopausal Syndrome Patients , 2001, Arzneimittelforschung.

[30]  Roy W Jones,et al.  A Prevalence Study of Age-Associated Memory Impairment , 1995, British Journal of Psychiatry.

[31]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[32]  J. Streicher,et al.  Diverse Actions of Ovarian Steroids in the Serotonin Neural System , 2002, Frontiers in Neuroendocrinology.

[33]  B. Sherwin,et al.  Estrogen and cognitive functioning in women. , 2003, Endocrine reviews.

[34]  D. Petitti,et al.  Hormone Use and Cognitive Performance in Women of Advanced Age , 2004, Journal of the American Geriatrics Society.

[35]  R. Littell.  SAS System for Mixed Models , 1996 .

[36]  M. Rice,et al.  Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project. , 2000, Archives of internal medicine.

[37]  F. Rodríguez‐Artalejo,et al.  Prevalence of age-associated memory impairment and dementia in a rural community. , 1993, Journal of neurology, neurosurgery, and psychiatry.